ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Safety"

  • 2016 American Transplant Congress

    Safety, Efficacy, and Cost Saving Potential of Various Weight-Based Dosing for Thymoglobulin Induction Therapy in Kidney Transplant Recipients.

    R. Miller,1 H. Meadows,1 S. Strout,1 T. Veasey,1 A. Mardis,1 J. Fleming,1 C. Mardis,1 N. Pilch,1 K. Chavin,2 D. Taber.2

    1Department of Pharmacy, Medical University of South Carolina, Charleston, SC; 2Department of Surgery, Medical University of South Carolina, Charleston, SC.

    Introduction: There are limited data assessing the appropriate weight to use when dosing Thymoglobulin for induction therapy. The aim of this study is to assess…
  • 2016 American Transplant Congress

    What Are the Benefits of Transvaginal Route for Kidney Extraction in Laparoscopic Living Donor Nephrectomy ?

    S. Hurel,1 M. Ariane,1 F. Audenet,1 C. Legendre,2 A. Mejean,1 M.-O. Timsit.1

    1Hôpital Européen Georges Pomidou, Paris, France; 2Hôpital Necker, Paris, France.

    Rationale and objectivesTransvaginal route for kidney extraction (TVE) emerged as new surgical option during laparoscopic donor nephrectomy to minimize scar and presumably to offer donors…
  • 2016 American Transplant Congress

    The Safety and Efficacy of Suspended Gasless Laparoscopy Living-Donor Nephrectomy in Renal Transplantation.

    J. Tian.

    Organ Transplantation Center, Qilu Hospital of Shandong University, Jinan, China.

    BACKGROUNDS: To develop a minimally invasive surgery for the kidney transplant donor and get the no CO2 pressure condition harvested kidney, we have developed suspended…
  • 2016 American Transplant Congress

    Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m2: A Comparison with the UNOS Registry.

    I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.

    Surgery, University of Illinois, Chicago, IL.

    Introduction:Obesity represents a barrier to kidney transplantation, but the increasing prevalence amongst renal failure patients has forced some centers to carefully consider such candidates. Morbidly…
  • 2016 American Transplant Congress

    Influence of Country-Associated Geographical Variables in the Ouctomes of Kidney Transplantation in Patients with HIV-Infection.

    M. Cristelli,1 F. Cofán,2 H. Tedesco-Silva,1 J. Trullas,3 D. Santos,1 C. Manzardo,4 F. Aguero,4 A. Moreno,4 F. Oppenheimer,2 F. Dieckmann,1 J. Miro,4 J. Medina-Pestana.1

    1Hospital do Rim-UNIFESP, São Paulo, Brazil; 2Nephrology, Hospital Clinic-IDIBAPS, Barcelona, Spain; 3Hospital de Olot, Girona, Spain; 4Infectology, Hospital Clinic-IDIBAPS, Barcelona, Spain.

    Objective: To evaluate effects of geographical factors on demography, clinical management and evolution of two cohorts of HIV-infected KT recipients.Methods: Observational, retrospective cohort study including…
  • 2015 American Transplant Congress

    Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors

    A. Rosen, B. Ho, M. Ison.

    Organ Transplantation and Infectious Diseases, Northwestern University, Chicago.

    Background: The Organ Procurement Transplant Network (OPTN) now requires enhanced screening of selected live donors for Trypanosoma cruzi, Strongyloides stercoralis, Tuberculosis (TB), and West Nile…
  • 2015 American Transplant Congress

    Temporal Increase in the Incidence of Post-Transplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients: Analysis of 2 US Insurance Administrative Claims Databases

    T. Kou, H.-U. Meier-Kriesche, J. Preston, A. Gomez.

    Bristol-Myers Squibb Company, Princeton, NJ.

    Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after kidney transplant. In a prior analysis using Medicare claims database from 1995 to 2003, the…
  • 2015 American Transplant Congress

    Normothermic Machine Perfusion (NMP) on Discarded Human Livers: The First Model in the US

    Q. Liu, A. Nassar, G. Iuppa, D. Urcuyo-Llanes, D. Sexton, T. Okamoto, T. Uso, A. Bennett, W. Baldwin, K. Abu-Elmagd, J. Fung, C. Miller, C. Quintini.

    Cleveland Clinic, Cleveland, OH.

    The benefit of NMP preservation has been reported in a number of animal studies. Herein we describe safety, feasibility and effectiveness of NMP on discarded…
  • 2015 American Transplant Congress

    Pre-Transplant Cardiac Troponin T (cTT) Is a Strong Predictor of Post Kidney Transplant Hospitalizations

    H. Amer, P. Geerdes, T. Fettes, R. Walker, E. Lorenz, F. Cosio.

    The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.

    Identifying patients at risk of re-hospitalization will permit improved monitoring and may decrease morbidity.We examined nine objective variables at the time of transplant and their…
  • 2015 American Transplant Congress

    Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

    C. Sommerer,1 K. Budde,1 V. Kliem,1 O. Witzke,1 M. Guba,1 J. Jacobi,1 B. Vogt,3 I. Hauser,1 P. Reinke,1 R. Stahl,1 T. Rath,1 M. Porstner,2 D. Baeumer,2 M. Zeier,1 W. Arns,1 F. Lehner.1

    1Herakles Study Group, Germany; 2Novartis Pharma, Nuremberg, Germany; 3Herakles Study Group, Switzerland.

    Aim: To compare safety and efficacy of 3 different immunosuppressive (IS) regimen 4years after renal transplantation (Tx).Methods: 802 patients (pts) were included in this 1year,…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences